Cartesian Therapeutics与Westgene Biopharma达成战略授权协议,加速体内CAR-T平台在自身免疫疾病领域的开发

美股速递
Jun 09

Cartesian Therapeutics宣布与Westgene Biopharma签署了一项战略授权协议,旨在加速其体内CAR-T平台在自身免疫疾病领域的开发进程。该合作将整合双方的技术专长与资源,共同推进创新疗法的研发,以应对当前未满足的医疗需求。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10